Professionals' attitudes towards the use of cognitive enhancers in academic settings

PLoS One. 2020 Nov 20;15(11):e0241968. doi: 10.1371/journal.pone.0241968. eCollection 2020.

Abstract

Introduction and aims: The non-medical use of prescription stimulants such as methylphenidate, dexamphetamine and modafinil is increasing in popularity within tertiary academic settings. There is a paucity of information on awareness, attitudes, and acceptability by professionals of use in this context. This study aimed to investigate professionals' knowledge of and attitudes towards the use of cognitive enhancers (CEs) in academic settings, and their willingness to use a hypothetical CE.

Design and methods: A mail survey was sent to doctors, pharmacists, nurses, accountants and lawyers in New Zealand. These disciplines were chosen as they require professional registration to practice. The questionnaire comprised four sections: (1) demographics, (2) knowledge of CEs, (3) attitudes towards the use of CEs, and (4) willingness to use hypothetical CEs.

Results: The response rate was 34.5% (414/1200). Overall, participants strongly disagreed that it was fair to allow university students to use CEs for cognitive enhancement (Mdn = 1, IQR: 1,3), or that it is ethical for students without a prescription to use cognitive enhancers for any reason (Mdn = 1, IQR: 1,2). Professions differed in their attitudes towards whether it is ethical for students without a prescription to use CEs for any reason (p = 0.001, H 31.527).

Discussion and conclusion: Divergent views and lack of clear consensus within professions and between professionals on the use of CEs have the potential to influence both professionals and students as future professionals. These divergent views may stem from differences in the core values of self-identity as well as extrinsic factors of acceptability within the profession in balancing the elements of opportunity, fairness and authenticity in cognitive enhancement. Further research is required to inform the development of policy and guidelines that are congruent with all professions.

MeSH terms

  • Adult
  • Aged
  • Attitude of Health Personnel
  • Central Nervous System Stimulants / therapeutic use
  • Cognition / drug effects*
  • Dextroamphetamine / therapeutic use
  • Female
  • Health Knowledge, Attitudes, Practice
  • Health Personnel / psychology*
  • Humans
  • Male
  • Methylphenidate / therapeutic use
  • Middle Aged
  • Modafinil / therapeutic use
  • New Zealand
  • Prescription Drugs / therapeutic use*
  • Students / psychology
  • Surveys and Questionnaires
  • Universities
  • Young Adult

Substances

  • Central Nervous System Stimulants
  • Prescription Drugs
  • Methylphenidate
  • Modafinil
  • Dextroamphetamine

Grants and funding

The author(s) received no specific funding for this work.